Feladilimab

Tax included
Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has the potential for the research of cancer.
MedChemExpress 
HY-P99363

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
Cancer-programmed cell death
CAS
2252518-85-5